- Joined
- Dec 18, 2015
- Messages
- 3,217
- Reaction score
- 4,930
An expansion factor (EF) for radiation oncologists was calculated in various scenarios using the following criteria. From ten Internet Archive-sampleable academic programs (Stanford, UTHSCA, Emory, WUSTL, UCLA, UCSF, MGH, OSU, IU, UNC) the number of active clinical MD attendings in radiation oncology were recorded from the years 2004 and 2019 respectively. An EF was calculated for each program. (E.g., Emory had 11 attendings in 2004 and 26 attendings in 2019 for an EF of 26/11 or 2.36). In 2004, there were 96 attendings in these 10 programs and 208 now for an average EF of 2.17 (range 0.83, 4.5).
Using NRMP match data, 128 radiation oncology residency spots were offered in 2004 and 207 in 2019 for an EF of 1.62. Using available workforce data and ASTRO data, there were 3997 active practicing radiation oncologists in the United States in 2004 and 5000 in 2019 for an EF of 1.25.
Using the Mann-Whitney test, EFs were compared between groups. Given that MD numbers only increase over time, a one-sided p-value of <0.05 was assumed to be significant. An EF of 1.62 for residency slots was assumed per program, consistent with historical data mentioned above.
Academic Attendings vs Residency Slots, 2004 vs 2019
EF=2.17 vs 1.62, p=0.24
Academic Attendings vs Practicing Rad Oncs, 2004 vs 2019
EF=2.17 vs 1.25, p<0.05
Residency Slots vs Practicing Rad Oncs, 2004 vs 2019
EF=1.62 vs 1.25, p<0.05
There's been a non-signficant trend of increasing attendings vs residents over time, although the increase in residency slots has generally attempted to keep pace with the increased number of attendings. However, given the author's personal laziness and desire not to waste HUGE amounts of time, only 10 programs were sampled. With more samples, the academic and residency EF discrepancy could likely become significant. That said, there has been a significant increase in attendings, and residency slots, vs practicing rad oncs in the US, over the last 15 years. (On a side note, the EF for residency slots 2000-2003 was exactly 1.0.)
Hope to get published in Red Journal. Should be a chip shot. (I said "chip" not "cheap.")
Using NRMP match data, 128 radiation oncology residency spots were offered in 2004 and 207 in 2019 for an EF of 1.62. Using available workforce data and ASTRO data, there were 3997 active practicing radiation oncologists in the United States in 2004 and 5000 in 2019 for an EF of 1.25.
Using the Mann-Whitney test, EFs were compared between groups. Given that MD numbers only increase over time, a one-sided p-value of <0.05 was assumed to be significant. An EF of 1.62 for residency slots was assumed per program, consistent with historical data mentioned above.
Academic Attendings vs Residency Slots, 2004 vs 2019
EF=2.17 vs 1.62, p=0.24
Academic Attendings vs Practicing Rad Oncs, 2004 vs 2019
EF=2.17 vs 1.25, p<0.05
Residency Slots vs Practicing Rad Oncs, 2004 vs 2019
EF=1.62 vs 1.25, p<0.05
There's been a non-signficant trend of increasing attendings vs residents over time, although the increase in residency slots has generally attempted to keep pace with the increased number of attendings. However, given the author's personal laziness and desire not to waste HUGE amounts of time, only 10 programs were sampled. With more samples, the academic and residency EF discrepancy could likely become significant. That said, there has been a significant increase in attendings, and residency slots, vs practicing rad oncs in the US, over the last 15 years. (On a side note, the EF for residency slots 2000-2003 was exactly 1.0.)
Hope to get published in Red Journal. Should be a chip shot. (I said "chip" not "cheap.")